The Combination of Sulfamethoxazole, Trimethoprim, and Isoniazid or Rifampin Is Bactericidal and Prevents the Emergence of Drug Resistance in Mycobacterium tuberculosis

Novel Inhibitors of InhA Efficiently KillMycobacterium tuberculosisunder Aerobic and Anaerobic Conditions

(2011) Catherine Vilchèze et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan

(2011) T.-S. Huang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Role of the Dihydrofolate Reductase DfrA (Rv2763c) in Trimethoprim-Sulfamethoxazole (Co-Trimoxazole) Resistance in Mycobacterium tuberculosis

(2010) C. U. Koser et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobacterium tuberculosis and Sulfamethoxazole Susceptibility

(2010) W. Ong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobacterium tuberculosis Dihydrofolate Reductase Is Not a Target Relevant to the Antitubercular Activity of Isoniazid

(2010) F. Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS)

(2010) Nivedita Nagachar et al.   FEMS MICROBIOLOGY LETTERS

Tuberculosis and Trimethoprim-Sulfamethoxazole

(2009) P. Forgacs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South Africa

(2009) Thomas R. Ioerger et al.   PLoS One